Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGF1R | P08069 | 1/20 | 0.52 |
| ▸ | CDK2 | P24941 | 15/20 | 0.48 |
| ▸ | CCNA2 | P20248 | 12/20 | 0.48 |
| ▸ | CCNA1 | P78396 | 12/20 | 0.48 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.46 |
| ▸ | CDK9 | P50750 | 3/20 | 0.45 |
| ▸ | CDK5 | Q00535 | 3/20 | 0.45 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.44 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.44 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.44 |
| ▸ | PAK3 | O75914 | 1/20 | 0.44 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.44 |
| ▸ | PAK2 | Q13177 | 1/20 | 0.44 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30458326 | 0.76 | CDK2 (0.61) | CDK2CCNA2CCNA1HCAR2CDK9 | |
| SCHEMBL18176972 | 0.75 | HCAR2 (0.49) | IGF1RCDK2CCNA2CCNA1HCAR2 | |
| SCHEMBL7175772 | 0.75 | CCNA2 (0.48) | IGF1RCDK2CCNA2CCNA1 | |
| SCHEMBL2959316 | 0.74 | CCNA2 (0.54) | IGF1RCDK2CCNA2CCNA1HCAR2 | |
| SCHEMBL17412844 | 0.72 | HCAR2 (0.53) | IGF1RCDK2CCNA2CCNA1HCAR2 | |
| SCHEMBL15831691 | 0.71 | HCAR2 (0.45) | IGF1RCDK2CCNA2CCNA1HCAR2 | |
| SCHEMBL27674559 | 0.71 | CCNA2 (0.52) | IGF1RCDK2CCNA2CCNA1 | |
| SCHEMBL29659491 | 0.71 | CCNA2 (0.70) | CDK2CCNA2CCNA1 | |
| SCHEMBL15109539 | 0.71 | IGF1R (0.78) | IGF1RNTRK1 | |
| SCHEMBL6384315 | 0.70 | IGF1R (0.61) | IGF1RCDK2CCNA2CCNA1CDK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023196975-A1 | COMPOUNDS THAT INTERACT WITH RAS SUPERFAMILY PROTEINS FOR TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE | SHY THERAPEUTICS, LLC (US) | 2023-10-12 | — | — | WO | disclosed |